SII

Being a student of science he always tries to implement the rules of science and technology in agriculture. Dibyaprakash, 25, of Village Aniapal, Block Koliana, Mayurbhanj, inherited farming…

New Delhi: The CEO of Serum Institute of India (SII), Adar Poonawalla, on Sunday urged nations to “be patient” amid the wait for Covishield, the COVID-19 vaccine developed by SII in…

Bhubaneswar: All frontline workers will be vaccinated at their respective workplace, said Director, Health and Family Welfare Bijay Panigrahi here on Wednesday. The vaccination of…

New Delhi: More than 300,000 people were vaccinated against COVID-19 in a single day for the first time on Friday. Nearly, 13,90,592 people have been inoculated since January 16 when the…

Pune: A fire broke out today at the Serum Institute of India (SII) at an under-construction facility. However, it is unlikely to hit the production of Covishield, the coronavirus vaccine…

Bhubaneswar: The second consignment of Covishield from Serum Institute, Pune reached Odisha by SpiceJet cargo flight. Sources in the Health and Family Welfare Department said Serum…

New Delhi: The government may place an order today for the Oxford vaccine that is likely to be priced at Rs 200 a vial in India, NDTV quoted sources from Adar Poonawalla's Serum Institute of…

New Delhi: The Drugs Controller General of India (DCGI) has approved Bharat Biotech's Covaxin for children above the age of 12 years while Oxford-AstraZeneca's vaccine Covishield,…

New Delhi: The new year couldn't have begun on a better note for Pune-based Serum Institute Of India (SII) with Covishield getting the nod for restricted emergency use in India after the…

New Delhi: India has finally got its vaccine against coronavirus. Two vaccines — Pune-based Serum Institute’s Covishield and Bharat Biotech's Covaxin — received emergency use approval from…